Description

Stimulate Spray (PT-141 + Oxytocin)

Stimulate Spray contains 5mg of PT-141 and 5mg of Oxytocin, totaling 0.1mg per spray and 10mg in total.

Brief Introduction

Stimulate Spray is a research product meticulously formulated for experimental purposes only. This innovative spray combines PT-141 and Oxytocin, two peptides studied for their potential effects on sexual function and arousal. It is crucial to emphasize that this product is designed exclusively for research applications.

Key Characteristics

• Combination of PT-141 and Oxytocin Peptides
• Precise formulation for research purposes
• Not intended for human use

Research Applications

Stimulate Spray is intended for laboratory or research settings, offering scientists and researchers a tool to explore the potential impacts of PT-141 and Oxytocin on sexual function and arousal.

Research Benefits

PT 141 and Erectile Dysfunction

PT-141, a melanocortin receptor agonist, has been investigated for its role in addressing erectile dysfunction. Studies have suggested its potential to improve penile function by stimulating melanocortin receptors in the central nervous system.

Oxytocin and Sexual Arousal

Oxytocin, often referred to as the “love hormone,” has been linked to various social behaviors and is under scrutiny for its potential influence on sexual arousal. Stimulate Spray provides researchers with an avenue to explore the impact of Oxytocin on sexual responses.

Potential Synergistic Effects

Combining PT-141 and Oxytocin in Stimulate Spray offers a unique opportunity to investigate potential synergistic effects. Research studies have hinted at the possibility of combined benefits in enhancing sexual function and arousal.

Summary

Stimulate Spray stands as a valuable research tool, providing scientists with a controlled environment to explore the effects of PT-141 and Oxytocin on sexual health. It is imperative to underscore that this product is not intended for human consumption, and its use should strictly adhere to ethical and regulatory research guidelines.

Disclaimer

This content is presented exclusively for educational purposes and should not be construed as medical advice. THE MATERIALS REFERENCED HEREIN ARE EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH USE.

Any clinical research initiatives must be conducted under the guidance of the relevant Institutional Review Board (IRB). Similarly, preclinical research involving animals must comply with the directives of the Institutional Animal Care and Use Committee (IACUC), adhering to the standards delineated by the Animal Welfare Act (AWA).

Our informational content is meticulously designed for research-oriented insights and is not a substitute for individual analysis and verification from credible sources before any purchasing decisions are made.

Upon finalizing your order and payment, you explicitly acknowledge and agree to adhere to our Terms and Conditions. Customer contentment stands as our paramount concern. If you are dissatisfied with the product received, kindly contact us at 419-707-5450 or email our support team at [email protected].

IMPORTANT NOTICE: All products showcased on our platform are EXCLUSIVELY INTENDED FOR LABORATORY AND RESEARCH APPLICATIONS. They are expressly not intended for veterinary or human utilization.

References

1. Molinoff PB, Shadiack AM, Earle D, Diamond LE, Quon CY. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003 Jun;994:96-102. doi: 10.1111/j.1749-6632.2003.tb03167.x. PMID: 12851303. [Read More].
2. Blaicher W, Gruber D, Bieglmayer C, Blaicher AM, Knogler W, Huber JC. The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest. 1999;47(2):125-6. doi: 10.1159/000010075. PMID: 9949283. [Read More].